XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.21.1

STOCK-BASED COMPENSATION | 3 Months Ended
--- | ---
Mar. 31, 2021
STOCK-BASED COMPENSATION |
STOCK-BASED COMPENSATION | 14 - STOCK-BASED COMPENSATION ​ 2015 Equity Incentive Plan ​ Stock Options ​ On February 23, 2021, the Company issued options to purchase 118,552 of the Company’s shares of common stock to certain individuals with an exercise price of $9.91 per share. One third of the options become exercisable on each of the first three anniversaries of February 23, 2021, with accelerated vesting that may occur following a change in control of the Company, and all unexercised options expire on the sixth anniversary of the grant date. The fair value of each option was estimated on the date of the grant using the Cox-Ross-Rubinstein pricing formula, resulting in a value of $4.33 per share, or $513 in the aggregate. The assumptions used in the Cox-Ross-Rubinstein option pricing formula are as follows: volatility of 60.91% (representing the Company’s historical volatility), a risk-free interest rate of 0.41%, a dividend yield of 0.98%, and expected life of 4 years (determined using the simplified method as outlined in SAB Topic 14 due to lack of historical exercise data). ​ For the three months ended March 31, 2021 and 2020, the Company recognized amortization expense of the fair value of these options, which is included in General and administrative expenses, as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​
​ | ​ | March 31, | ​
​ | ​ | 2021 |  | 2020 |
General and administrative expenses | ​ | $ | 180 | ​ | $ | 205 | ​
​ Amortization of the unamortized stock-based compensation balance of $823 as of March 31, 2021 is expected to be expensed $456, $278, $81 and $8 during the remainder of 2021 and during the years ending December 31, 2022, 2023 and 2024, respectively. The following table summarizes the stock option activity for the three months ended March 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted | ​ | Weighted | ​ | ​ | ​
​ | ​ | Number | ​ | Average | ​ | Average | ​ | ​ | ​
​ | ​ | of | ​ | Exercise | ​ | Fair | ​ | ​ | ​
​ |  | Options |  | Price |  | Value |  | ​ | ​
Outstanding as of January 1, 2021 |  | 837,338 |  | $ | 8.86 | ​ | ​ | 4.02 | ​ | ​ | ​
Granted |  | 118,552 | ​ | ​ | 9.91 | ​ | ​ | 4.33 | ​ | ​ | ​
Exercised |  | (16,742) | ​ | ​ | 7.47 | ​ | ​ | 2.72 | ​ | ​ | ​
Forfeited |  | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding as of March 31, 2021 |  | 939,148 |  | $ | 9.02 | ​ | $ | 4.08 | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable as of March 31, 2021 |  | 511,830 |  | $ | 9.84 | ​ | $ | 5.00 | ​ | ​ | ​
​ The following table summarizes certain information about the options outstanding as of March 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Options Outstanding and Unvested, | ​ | Options Outstanding and Exercisable, | ​
​ | ​ | ​ | March 31, 2021 | ​ | March 31, 2021 | ​
Weighted | ​ | ​ | ​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ |  | ​ | ​ | Weighted | ​
Average |  | ​ | ​ | Weighted | ​ | Average | ​ | ​ | ​ | Weighted | ​ | Average | ​
Exercise Price of |  | ​ | ​ | Average | ​ | Remaining | ​ | ​ | ​ | Average | ​ | Remaining | ​
Outstanding | ​ | Number of | ​ | Exercise | ​ | Contractual | ​ | Number of | ​ | Exercise | ​ | Contractual | ​
Options |  | Options |  | Price |  | Life |  | Options |  | Price |  | Life |
$ | 9.02 |  | 427,318 | ​ | $ | 8.04 | ​ | 5.00 | ​ | 511,830 | ​ | $ | 9.84 | ​ | 3.38 | ​
​ As of March 31, 2021 and December 31, 2020, a total of 939,148 and 837,338 stock options were outstanding, respectively. ​ Restricted Stock Units ​ The Company has issued restricted stock units (“RSUs”) under the 2015 Plan to certain members of the Board of Directors and certain executives and employees of the Company, which represent the right to receive a share of common stock, or in the sole discretion of the Company’s Compensation Committee, the value of a share of common stock on the date that the RSU vests. As of March 31, 2021 and December 31, 2020, 478,848 and 373,588 shares of the Company’s common stock were outstanding in respect of the RSUs, respectively. Such shares of common stock will only be issued in respect of vested RSUs issued to directors when the director’s service with the Company as a director terminates. Such shares of common stock will only be issued to executives and employees when their RSUs vest under the terms of their grant agreements and the amended 2015 Plan. ​ The RSUs that have been issued to certain members of the Board of Directors generally vest on the date of the annual shareholders meeting of the Company following the date of the grant. In lieu of cash dividends issued for vested and nonvested shares held by certain members of the Board of Directors, the Company will grant additional vested and nonvested RSUs, respectively, which are calculated by dividing the amount of the dividend by the closing price per share of the Company’s common stock on the dividend payment date and will have the same terms as other RSUs issued to members of the Board of Directors. The RSUs that have been issued to other individuals vest ratably on each of the three anniversaries of the determined vesting date. The table below summarizes the Company’s unvested RSUs for the three months ended March 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Weighted | ​
​ | Number of | ​ | Average Grant | ​
​ | RSUs | ​ | Date Price | ​
Outstanding as of January 1, 2021 | 298,834 | ​ | $ | 7.49 | ​
Granted | 103,870 | ​ | ​ | 9.91 | ​
Vested | (105,458) | ​ | ​ | 8.29 | ​
Forfeited | — | ​ | ​ | — | ​
​ | ​ | ​ | ​ | ​ | ​
Outstanding as of March 31, 2021 | 297,246 | ​ | $ | 8.06 | ​
​ The total fair value of the RSUs that vested during the three months ended March 31, 2021 and 2020 was $1,130 and $351, respectively. The total fair value is calculated as the number of shares vested during the period multiplied by the fair value on the vesting date. ​ The following table summarizes certain information of the RSUs unvested and vested as of March 31, 2021: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unvested RSUs | ​ | Vested RSUs | ​
March 31, 2021 | ​ | March 31, 2021 | ​
​ | ​ | ​ | ​ | Weighted | ​ | ​ | ​ | ​ | ​
​ | ​ | Weighted | ​ | Average | ​ | ​ | ​ | Weighted | ​
​ | ​ | Average | ​ | Remaining | ​ | ​ | ​ | Average | ​
Number of | ​ | Grant Date | ​ | Contractual | ​ | Number of | ​ | Grant Date | ​
RSUs |  | Price |  | Life |  | RSUs |  | Price |
297,246 | ​ | $ | 8.06 | ​ | 1.88 | ​ | 611,355 | ​ | $ | 10.59 | ​
​ The Company is amortizing these grants over the applicable vesting periods, net of anticipated forfeitures. As of March 31, 2021, unrecognized compensation cost of $1,534 related to RSUs will be recognized over a weighted-average period of 1.88 years. ​ For the three months ended March 31, 2021 and 2020, the Company recognized nonvested stock amortization expense for the RSUs, which is included in General and administrative expenses as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​
​ | ​ | March 31, | ​
​ |  | 2021 |  | 2020 |
General and administrative expenses | ​ | $ | 342 | ​ | $ | 276 | ​
​

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration